Exact Mass: 582.147
Exact Mass Matches: 582.147
Found 297 metabolites which its exact mass value is equals to given mass value 582.147
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
10-Acetoxyligustroside
10-Acetoxyligustroside is found in herbs and spices. 10-Acetoxyligustroside is a constituent of osmanthus leaves (Osmanthus fragrans). Constituent of osmanthus leaves (Osmanthus fragrans). 10-Acetoxyligustroside is found in herbs and spices.
Kuwanon Y
Kuwanon Y is found in fruits. Kuwanon Y is a constituent of Morus alba (white mulberry). Constituent of Morus alba (white mulberry). Kuwanon Y is found in fruits.
Norrubrofusarin 6-beta-gentiobioside
Norrubrofusarin 6-beta-gentiobioside is found in coffee and coffee products. Norrubrofusarin 6-beta-gentiobioside is a constituent of the seeds of Cassia tora (charota)
5'-Methoxybilobetin
5-Methoxybilobetin is found in fats and oils. 5-Methoxybilobetin is isolated from Ginkgo biloba (ginkgo). Isolated from Ginkgo biloba (ginkgo). 5-Methoxybilobetin is found in ginkgo nuts and fats and oils.
Ivosidenib
Naringin dihydrochalcone
(2R)-Naringenin 8-C-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside
(2r)-naringenin 8-c-alpha-l-rhamnopyranosyl-(1->2)-beta-d-glucopyranoside is soluble (in water) and a very weakly acidic compound (based on its pKa). (2r)-naringenin 8-c-alpha-l-rhamnopyranosyl-(1->2)-beta-d-glucopyranoside can be found in loquat, which makes (2r)-naringenin 8-c-alpha-l-rhamnopyranosyl-(1->2)-beta-d-glucopyranoside a potential biomarker for the consumption of this food product.
Naringin_dihydrochalcone
Naringin dihydrochalcone is a member of flavonoids and a glycoside. Naringin Dihydrochalcone is an artificial sweetener derived from naringin. Naringin is a major flavanone glycoside obtained from tomatoes, grapefruits, and many other citrus fruits. Naringin exhibits biological properties such as antioxidant, anti-inflammatory, and antiapoptotic activities. Naringin suppresses NF-κB signaling pathway. Naringin Dihydrochalcone is an artificial sweetener derived from naringin. Naringin is a major flavanone glycoside obtained from tomatoes, grapefruits, and many other citrus fruits. Naringin exhibits biological properties such as antioxidant, anti-inflammatory, and antiapoptotic activities. Naringin suppresses NF-κB signaling pathway.
2,6-Dihydroxy-4-methoxy-5-C-methyl-3-C-[5,7-dihydroxy-3-methoxyflavon-8-yl]dihydrochalcone
Epicatechin 3-O-(2-trans-cinnamoyl-beta-D-allopyranoside)
2'-O-Vanilloylvitexin
Epicatechin 3-O-(3-trans-cinnamoyl-beta-D-allopyranoside)
4-hydroxymethyl-2-methoxyphenyl 1-O-beta-D-[5-O-(4-methoxybenzoyl)]apiofuranosyl-(1->6)-beta-D-glucopyranoside
2,6-Di-Me ether,8-O-primeveroside-1,2,6,8-Tetrahydroxyxanthone
(5S,6S,7R,8S)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-<2-(2-penylethyl)-7-hydroxy-chromonyl-6-oxy>chromone|(5S,6S,7R,8S)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-penylethyl)-7-hydroxy-chromonyl-6-oxy]chromone|(5S,6S,7R,8S)-2-(2-Phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenyl-ethyl)-7-hydroxy-chromonyl-6-oxy]-chromone (AH15)|AH15
Me glycoside, 4, 5, 7, 8, 9-penta-Ac, benzyl ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI
6-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl]-1,3-dihydroxy-7-methoxyxanthone|polygalaxanthone V
1-C-(2-[(benzyloxy)methyl]-4-hydroxyphenyl) 4-O-D-glucopyranosyl-(1->3)-(1-deoxy-2-O-methyl-beta-D-glucopyranoside|Symplomoside
2,8-Di-Me ether,1-O-primeveroside-1,2,6,8-Tetrahydroxyxanthone
7-Hydroxy-3,8-dimethoxy-1--xanthon|7-hydroxy-3,8-dimethoxyxanthone-1-O-[beta-D-xylosyl(1->6)]-beta-D-glucopyranoside|gentiabavaroside|Gentiacaulosid
(1aR,1bS,2S,5aR,6R,6aS)-2-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-1a,1b,2,5a,6,6a-hexahydro-5a,6-dihydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-5-carboxylic acid methyl ester|6-O-beta-D-galactopyranosylsesamoside
callophycoic acid C
A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine-2-carboxylic acid with an isolated double bond between positions 6a and 7 and is substituted by a bromo, 2-[(1S,3S,6S)-3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl]ethyl and a methyl group at positions 9, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). It is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.
Okanin 4-alpha-L-arabinofuranosyl-(1->4)-glucoside
1-O-[beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranosyl]-8-hydroxy-3,5-dimethoxyxanthone
5,7,3,4-Tetrahydroxyflavanone 7-alpha-L-arabinofuranosyl-(1->6)-glucoside
Me glycoside,4,6,-O-benzylidene,2,3,3,4-tetra-Ac-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-mannose
EGCG-ph|epigallocatechin-3-O-gallat-(4beta-2)-phloroglucinol|epigallocatechin-3-O-gallate-(4beta->2)-ph
quercetin 3-O-(6-O-phenylacetyl)-beta-D-glucopyranoside|thotneoside B
ethyl 4-(7-acetyl-4,6-dihydroxy-3,5-dimethyl-2-oxo-2,3-dihydrobenzofuran-3-yl)-4-(7-acetyl-4,6-dihydroxy-3,5-dimethylbenzofuran-2-yl)-3-oxobutanoate
2?,3?-dihydroxy-4?-methoxydibenzoyl-4?-O-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranoside|sophodibenzoside A
2?-alpha-L-rhamnopyranosyloxybenzyl 6-alpha-L-rhamnopyranosyloxy-3-hydroxy-2-methoxybenzoate
2?,4?-dihydroxy-3?-methoxydibenzoyl-4?-O-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranoside|sophodibenzoside J
hedyotosides B|maltol 6?-O-(5-O-caffeoyl)-beta-d-apiofuranosyl-beta-d-glucopyranoside|shimobashiraside A
7-O-[alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranosyl]-1,8-dihydroxy-3-methoxyxanthone|kouitchenside I
7-O-(α-L-rhamnopyranosyl)-8-O-(β-D-glucopyranosyl)-1-hydroxy-3-methoxyxanthone|kouitchenside J
2?,3?-dihydroxy-4?-methoxydibenzoyl-4?-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranoside|sophodibenzoside B
2,4,6-trihydroxydihydrochalcone 2,4-di-O-beta-D-glucopyranoside|schoepfiajasmin D
5-(beta-D-glucopyranosyl)-3-hydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl alpha-L-rhamnopyranoside|glycyphyllin C|phloretin 2-alpha-O-L-rhamnopyranosyl-4-beta-O-D-glucopyranosyl diglycoside
(2R,3R)-dihydrokaempferol 3-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranoside|pteleifoside F
(7R,8S,7?R,8?S)-5-methoxyprinsepiol-4-O-beta?D-glucopyranoside
callophycoic acid D
A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine-2-carboxylic acid with an isolated double bond between positions 6 and 6a and is substituted by a bromo, 2-[(1S,3S,6S)-3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl]ethyl and a methyl group at positions 9, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). An isomer of callophycoic acid C, it is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.
4-methoxyphenyl 1-O-beta-D-[5-O-(3,4-dimethoxybenzoyl)]-apiofuranosyl-(1->6)-beta-D-glucopyranoside|4-Methoxyphenyl 1-O-??-D-[5-O-(3,4-dimethoxybenzoyl)]-apiofuranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
3,5-bis-4beta-D-glucopyranosyloxy-3-methoxy-trans-stilbene-4-ol
(2S)-2,3-dihydro-6-methylginkgetin|2,3-dihydro-6-methylginkgetin
4-O-[alpha-L-Arabinofuranosyl(1鈥樏傗垎4)-beta-D-glucopyranoside]-2,3,3,4,4-Pentahydroxychalcone
α-Glucosidase-IN-24
1-Hydroxy-2,6-dimethoxy-8-(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyloxy)xanthone is a natural product found in Swertia kouitchensis with data available.
C27H34O14_3-Phenyl-1-{2,4,6-trihydroxy-3,5-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]phenyl}-1-propanone
methyl (4S,5Z,6S)-5-(2-acetyloxyethylidene)-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
methyl (4S,5Z,6S)-5-(2-acetyloxyethylidene)-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_55.4\\%
methyl (4S,5Z,6S)-5-(2-acetyloxyethylidene)-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_major
methyl (4S,5Z,6S)-5-(2-acetyloxyethylidene)-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_minor
Norrubrofusarin 6-b-gentiobioside
10-Acetoxyligustroside
5-Methoxybilobetin
(2S,3S,4S,5R,6R)-6-((7,8-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)methoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
AG-120
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168618 - IDH1 inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors IDH1 Inhibitor 8 (91) is isocitrate dehydrogenase 1 (IDH1) inhibitor. IDH1 Inhibitor 8 can be used for the research of cancer[1]. Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity[1].
(S)-(-)-(6,6-Dimethoxybiphenyl-2,2-diyl)bis(diphenylphosphine)
1,3-bis(3-chloropropyl)tetrakis-(trimethylsiloxy)disiloxane,tech-95
(1S)-1-(Diphenylphosphino)-2-[(1R)-1-(diphenylphosphino)ethyl]ferrocene
1-[4-[(2R,3S,4R,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one
6-[(10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl)oxymethyl]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2R)-Naringenin 8-C-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside
4-O-demethylknipholone-4-O-beta-D-glucopyranoside
An anthraquinone that is knipholone in which the O-methyl group is replaced by a beta-D-glucopyranosyl group. It is isolated from the roots of Bulbine frutescens and exhibits trypanocidal and antiplasmodial activities.
1-[2,4,6-Trihydroxy-3,5-bis(beta-D-glucopyranosyl)phenyl]-3-phenyl-1-propanone
2,3,4-tris-O-[(4-hydroxyphenyl)acetyl]-beta-D-glucopyranose
3,4,5-Trihydroxy-6-[4-(4-hydroxyphenyl)-8,8-dimethyl-6-(2-methylpropanoyl)-2-oxopyrano[2,3-h]chromen-5-yl]oxyoxane-2-carboxylic acid
methyl (3E)-3-[2-(acetyloxy)ethylidene]-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-carboxylate
(R,S)-Ivosidenib
(R,S)-Ivosidenib ((R,S)-AG-120) is the less active enantiomer of Ivosidenib (AG-120)[1].
J-2156 (TFA)
J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156 TFA has anti-inflammatory activity and it is used for the relief of mechanical allodynia and mechanical hyperalgesia in the ipsilateral hindpaws in rats[1][2].
4-[(1r,5s,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-6-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol
10-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 2-hydroxy-2-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate
methyl (1s,4ar,6s,7r,7as)-4a,7-dihydroxy-6-{[(2e)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}-7-methyl-1-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
ethyl 4-(7-acetyl-4,6-dihydroxy-3,5-dimethyl-1-benzofuran-2-yl)-4-(7-acetyl-4,6-dihydroxy-3,5-dimethyl-2-oxo-1-benzofuran-3-yl)-3-oxobutanoate
1-(3-acetyl-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione
6-{[3-(acetyloxy)butanoyl]oxy}-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-(acetyloxy)butanoate
5-hydroxy-8-{5-[(2s)-5-hydroxy-7-methoxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-2-methoxyphenyl}-2-(4-hydroxyphenyl)-7-methoxychromen-4-one
(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,10-tetraene-5-carboxylic acid
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,3ar,4s,4's,5'r,6s,7ar)-4'-(benzoyloxy)-3a,4-dihydroxy-5'-methyl-3-oxo-tetrahydro-4h-spiro[1-benzofuran-2,2'-oxane]-6-carboxylate
2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-phenylprop-2-enoate
(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[(3s,4r,5r)-3,4-dihydroxy-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-methoxyphenoxy)oxan-2-yl]methoxy}oxolan-3-yl]methyl 3,4-dimethoxybenzoate
2-hydroxy-1,6-dimethoxy-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one
(1s,2s,3s,7s,8r,9r,10r,11s,13s,14r,17r)-7,9,10-tris(acetyloxy)-13-chloro-8,17-dimethyl-4,12-dimethylidene-16-oxo-15,18-dioxatetracyclo[9.6.1.0¹,¹⁴.0³,⁸]octadecan-2-yl acetate
(2s)-2-[(2r,3r)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2r)-2-[(1ar,1bs,3r,3ar,5r,7br,9r)-3,9-bis(acetyloxy)-1a-[(acetyloxy)methyl]-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethyl acetate
(4s,5z,6s)-5-(2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}ethylidene)-4-(2-methoxy-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylic acid
2-[(2r,3r)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-[(1r,5s,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-5-[(1e)-2-(2,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol
[(3s,4r,5r)-3,4-dihydroxy-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[4-(hydroxymethyl)-2-methoxyphenoxy]oxan-2-yl]methoxy}oxolan-3-yl]methyl 4-methoxybenzoate
2,7,9-tris(acetyloxy)-13-chloro-8,17-dimethyl-4,12-dimethylidene-16-oxo-15,18-dioxatetracyclo[9.6.1.0¹,¹⁴.0³,⁸]octadecan-10-yl acetate
(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,11-tetraene-5-carboxylic acid
[(3s,4r,5r)-5-{[(2r,3s,4s,5r,6s)-6-(3,4-dimethoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxy}-3,4-dihydroxyoxolan-3-yl]methyl 4-methoxybenzoate
(2r)-2-[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3,9-bis(acetyloxy)-1a-[(acetyloxy)methyl]-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethyl acetate
(7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,18,20-tetraen-17-one
3,4-dimethoxyphenyl1-o-β-d-[5-o-(4-methoxybenzoyl)]-apiofura-nosyl-(1→6)-β-d-glucopyranoside
{"Ingredient_id": "HBIN007438","Ingredient_name": "3,4-dimethoxyphenyl1-o-\u03b2-d-[5-o-(4-methoxybenzoyl)]-apiofura-nosyl-(1\u21926)-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H34O14","Ingredient_Smile": "COC1=CC=C(C=C1)C(=O)OCC2(COC(C2O)OCC3C(C(C(C(O3)OC4=CC(=C(C=C4)OC)OC)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6286","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-methoxyphenyl1-o-β-d-[5-o-(3,4-dimethoxybenzoyl)]-apio-furanosyl-(1→6)-β-d-glucopyranoside
{"Ingredient_id": "HBIN010641","Ingredient_name": "4-methoxyphenyl1-o-\u03b2-d-[5-o-(3,4-dimethoxybenzoyl)]-apio-furanosyl-(1\u21926)-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H34O14","Ingredient_Smile": "COC1=CC=C(C=C1)OC2C(C(C(C(O2)COC3C(C(CO3)(COC(=O)C4=CC(=C(C=C4)OC)OC)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14048","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,3'-dibenzoyloxy-3,6,7,4'-tetramethoxyflavone
{"Ingredient_id": "HBIN011015","Ingredient_name": "5,3'-dibenzoyloxy-3,6,7,4'-tetramethoxyflavone","Alias": "NA","Ingredient_formula": "C33H26O10","Ingredient_Smile": "COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)C4=CC=CC=C4)OC)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5386","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}